A carregar...
Extreme Prostate‐Specific Antigen Response to Infusional 5‐Flourouracil in Castrate‐Resistant Prostate Cancer
Prostate cancer that has progressed after androgen deprivation, abiraterone, and taxane therapy is challenging to treat successfully. Herein we report a dramatic response to continuous‐infusion 5‐fluorouracil (5‐FU) at a dose of 200 mg/m(2) in a patient with rapidly progressive, heavily pretreated,...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905692/ https://ncbi.nlm.nih.gov/pubmed/29259071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0450 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|